Portugal, June 19 -- Portugal based EISAI FARMACEUTICA, Unipessoal Lda. has secured contract from Unidade Local De Saude Amadora/Sintra, E.P.E. for Lenvatinib Acquisition (Kisplyx) 10Mg Cap, Lab Eisai, For Ulsasi, For The Year 2025. The value of the contract is worth 11325110 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....